Scholarlink

<p>The interaction of vanadium compounds of pharmaceutical interest with metal-transport proteins like human serum transferrin (hTF) is poorly understood. Direct structural evidence identifying vanadium binding sites on hTF is still lacking. Here, the X-ray structure of the adduct formed when the potential drug [V<sup>IV</sup>O(acac)<sub>2</sub>], with acac = acetylacetonato, reacts with human serum transferrin with Fe<sup>3+</sup> bound at the C-lobe only (Fe<sub>C</sub>-hTF) has been solved and compared with new structures of Fe<sub>C</sub>-hTF used as controls. Structural analysis revealed the presence of a [V<sup>V</sup><sub>2</sub>O<sub>6</sub>]<sup>2–</sup> anion that can be described as a divanadate(V) anion, [V<sup>V</sup><sub>2</sub>O<sub>7</sub>]<sup>4–</sup>, that has one oxygen replaced by the phenolate oxygen of Tyr188. The two vanadium centers adopt tetrahedral geometry, consistent with V<sup>V</sup> behavior. The binding does not alter the overall conformation of Fe<sub>C</sub>-hTF that retains the open conformation of the N-lobe and the closed conformation of the C-lobe, remaining able to be recognized by the transferrin receptor.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

First crystal structure of an adduct formed upon reaction of a vanadium compound with human serum transferrin

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月16日

查看全文
  • Anne-Sophie Banneville,
  • Rosanna Lucignano,
  • Maddalena Paolillo,
  • Virginia Cuomo,
  • Marco Chino,
  • Giarita Ferraro,
  • Delia Picone,
  • Eugenio Garribba,
  • Irina Cornaciu-Hoffmann,
  • Andrea Pica,
  • Antonello Merlino

摘要

The interaction of vanadium compounds of pharmaceutical interest with metal-transport proteins like human serum transferrin (hTF) is poorly understood. Direct structural evidence identifying vanadium binding sites on hTF is still lacking. Here, the X-ray structure of the adduct formed when the potential drug [VIVO(acac)2], with acac = acetylacetonato, reacts with human serum transferrin with Fe3+ bound at the C-lobe only (FeC-hTF) has been solved and compared with new structures of FeC-hTF used as controls. Structural analysis revealed the presence of a [VV2O6]2– anion that can be described as a divanadate(V) anion, [VV2O7]4–, that has one oxygen replaced by the phenolate oxygen of Tyr188. The two vanadium centers adopt tetrahedral geometry, consistent with VV behavior. The binding does not alter the overall conformation of FeC-hTF that retains the open conformation of the N-lobe and the closed conformation of the C-lobe, remaining able to be recognized by the transferrin receptor.